Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Valbenazine Capsules had annual sales of US $1,993.6 mn in the United States (IQVIA MAT June 2024)
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
ALS is a rare, progressive and fatal neurodegenerative disease, with an average life expectancy of 3 to 5 years from the time of symptom onset
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
The product is used to treat amyotrophic lateral sclerosis
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Subscribe To Our Newsletter & Stay Updated
